U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07631143) titled 'Intermittent Low Oxygen Breathing: A First Study Testing Different Disease Stages in People Living With MS' on May 13.

Brief Summary: This study will look at the safety, tolerability and feasibility of a non-invasive treatment called Acute Intermittent Hypoxia (AIH) in people with Multiple Sclerosis (MS) at different stages of the disease course.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Multiple Sclerosis

Intervention: OTHER: Acute Intermittent Hypoxia

Hypoxia (10% O2) will be administered via a non-rebreather face mask connected to an oxygen tank supplying the 10% O2. Each session will involve 15 cycles...